PHARMACEUTICAL FORMULATION COMPRISING LEVOTHYROXINE SODIUM

摘要

There is provided a stable pharmaceutical formulation comprising (a) an effective amount of levothyroxine sodium, (b) microcrystalline cellulose whi ch has a mean particle size of less than 125~m and is present in an amount of 6 0 to 85% w/w based upon the total weight of the formulation, and (c) pregelatinised starch present in an amount of 5 to 30% w/w based upon total weight of the formulation. There is also provided a process for the preparation of such a formulation.